The insulin pump known as CSII mainly adopts the form of a basal dose and bonus dose to input insulin, allowing for intensive insulin therapy, which can achieve continuous insulin microinput for 24 hours according to the body's normal insulin secretion in order to stably control blood sugar and reduce risks of hyperglycemia and hypoglycemia [14]. Here, INS is linked to Hyperglycemia.